Bortezomib-related colon mucositis in a multiple myeloma patient.
Siniscalchi
Agostina
A
Tendas
Andrea
A
Ales
Micaela
M
Fratoni
Stefano
S
Cupelli
Luca
L
Dentamaro
Teresa
T
Scaramucci
Laura
L
Giovannini
Marco
M
Caravita
Tommaso
T
Santeusanio
Giuseppe
G
Niscola
Pasquale
P
de Fabritiis
Paolo
P
D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001897:Boronic Acids / Q000009:adverse effects* / Q000627:therapeutic use; D000069286:Bortezomib; D003108:Colonic Diseases / Q000139:chemically induced; D006801:Humans; D008297:Male; D008875:Middle Aged; D052016:Mucositis / Q000139:chemically induced*; D009101:Multiple Myeloma / Q000188:drug therapy / Q000503:physiopathology; D011719:Pyrazines / Q000009:adverse effects* / Q000627:therapeutic use; D051437:Renal Insufficiency / Q000209:etiology
D000970:Antineoplastic Agents; D001897:Boronic Acids; D011719:Pyrazines; D000069286:Bortezomib